Mereo BioPharma (MREO) Treasury Shares (2018 - 2026)

Mereo BioPharma (MREO) has reported Treasury Shares for 6 consecutive years, with $1.2 million the latest figure, recorded in Q4 2023.

• Quarterly Treasury Shares fell 0.88% year-over-year to $1.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.2 million (down 0.88% YoY) and the FY2023 annual result came in at $1.2 million, down 7.87% from the prior year.
• Treasury Shares eased to $1.2 million in Q4 2023 per MREO's latest filing, from $1.3 million in the prior quarter.
• Over the last five years, Treasury Shares for MREO reached as high as $1.6 million in Q1 2026 and fell as low as $408230.7 in Q4 2022.
• A 5-year average of $981005.5 and a median of $979608.0 in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2019 — Treasury Shares jumped 324.74% — and 2022, when it dropped 19.25%.
• Year by year, Treasury Shares stood at $1.7 million in 2019, then advanced by 2.7% to $1.7 million in 2020, then slipped by 10.82% to $1.5 million in 2021, then fell by 19.25% to $1.2 million in 2022, then decreased by 0.88% to $1.2 million in 2023.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.2 million, $1.3 million, and $1.2 million for Q4 2023, Q2 2023, and Q4 2022 respectively.